Among over\u00a0800 specialists and 70 experts in myology from the\u00a05 continents, the researchers from the 4 laboratories (Genethon, Institute of Myology, I-Stem and Atlantic Gene Therapies) of the Biotherapies Institute of Rare Disease, will also be there and speak up throughout the week to present their newest progress.\u00a0There will be researchers from the Institute of Myology\u00a0(Sonia Berrih-Aknin, Denis Furling, Olivier Benveniste…), from Genethon (Isabelle Richard, Ana Buj-Bello…), from I-Stem (Suzie Lefebvre, C\u00e9cile Martinat…) and from\u00a0Atlantic Gene Therapies (Caroline Le Guiner…).<\/p>\n
Around 60\u00a0posters\u00a0of researchers from the Biotherapies Institute for Rare Diseases will be displayed to delegates.\u00a0All in all,\u00a010 plenary sessions and 14 symposia will focus on current issues of myology such as stem cells in muscular development, neuromuscular interactions, therapeutic approaches, particularly the most advanced\u00a0(gene therapy, exon skipping, pharmacog\u00e9nomics…), the latest progress in therapeutics for the heart,\u00a0a vital muscle…<\/p>\n
Mon, March 14, 6pm<\/strong>: Opening Lecture celebrating the 30th<\/sup> anniversary of the discovery of the gene involved in Duchenne Muscular Distrophy by Kenneth Fischbeck (one of the publication’ signatories)<\/p>\n Tue, March 15:<\/strong> Fundamental muscle biology and neuromuscular junction<\/p>\n Wed, March 16 and Thu, March 17:<\/strong> Focus on the therapeutics under trial or being developed for neuromuscular diseases<\/p>\n Fri, March 18:<\/strong> Focus on the heart and on the advanced therapies being developed (cell therapy, gene therapy) ; Closing conference on the advanced technology Crispr9 and its practical application on Duchenne Muscular Distrophy.<\/p>\n <\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" With speakers from the Biotherapies\u00a0Institute of Rare Diseases Among over\u00a0800 specialists and 70 experts in myology from the\u00a05 continents, the researchers from the 4 laboratories (Genethon, Institute of Myology, I-Stem and Atlantic Gene Therapies) of the Biotherapies Institute of Rare Disease, will also be there and speak up throughout the week to present their newest … [Read more]<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-5309","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/5309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/comments?post=5309"}],"version-history":[{"count":6,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/5309\/revisions"}],"predecessor-version":[{"id":5320,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/5309\/revisions\/5320"}],"wp:attachment":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/media?parent=5309"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/categories?post=5309"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/tags?post=5309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}